David Harlan to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications David Harlan has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.063
-
Harlan DM, von Herrath M. Immune intervention with anti-CD3 in diabetes. Nat Med. 2005 Jul; 11(7):716-8.
Score: 0.063
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.